677 related articles for article (PubMed ID: 28550093)
1. Causal Effect of Plasminogen Activator Inhibitor Type 1 on Coronary Heart Disease.
Song C; Burgess S; Eicher JD; O'Donnell CJ; Johnson AD
J Am Heart Assoc; 2017 May; 6(6):. PubMed ID: 28550093
[TBL] [Abstract][Full Text] [Related]
2. Exploring the Causal Pathway From Telomere Length to Coronary Heart Disease: A Network Mendelian Randomization Study.
Zhan Y; Karlsson IK; Karlsson R; Tillander A; Reynolds CA; Pedersen NL; Hägg S
Circ Res; 2017 Jul; 121(3):214-219. PubMed ID: 28515044
[TBL] [Abstract][Full Text] [Related]
3. Exploring the causal pathway from omega-6 levels to coronary heart disease: A network Mendelian randomization study.
Liao LZ; Li WD; Liu Y; Li JP; Zhuang XD; Liao XX
Nutr Metab Cardiovasc Dis; 2020 Feb; 30(2):233-240. PubMed ID: 31648883
[TBL] [Abstract][Full Text] [Related]
4. Genetic Association of Waist-to-Hip Ratio With Cardiometabolic Traits, Type 2 Diabetes, and Coronary Heart Disease.
Emdin CA; Khera AV; Natarajan P; Klarin D; Zekavat SM; Hsiao AJ; Kathiresan S
JAMA; 2017 Feb; 317(6):626-634. PubMed ID: 28196256
[TBL] [Abstract][Full Text] [Related]
5. Causal effects of body mass index on cardiometabolic traits and events: a Mendelian randomization analysis.
Holmes MV; Lange LA; Palmer T; Lanktree MB; North KE; Almoguera B; Buxbaum S; Chandrupatla HR; Elbers CC; Guo Y; Hoogeveen RC; Li J; Li YR; Swerdlow DI; Cushman M; Price TS; Curtis SP; Fornage M; Hakonarson H; Patel SR; Redline S; Siscovick DS; Tsai MY; Wilson JG; van der Schouw YT; FitzGerald GA; Hingorani AD; Casas JP; de Bakker PI; Rich SS; Schadt EE; Asselbergs FW; Reiner AP; Keating BJ
Am J Hum Genet; 2014 Feb; 94(2):198-208. PubMed ID: 24462370
[TBL] [Abstract][Full Text] [Related]
6. Blood lipid levels mediating the effects of sex hormone-binding globulin on coronary heart disease: Mendelian randomization and mediation analysis.
Yang J; Zhou J; Liu H; Hao J; Hu S; Zhang P; Wu H; Gao Y; Tang W
Sci Rep; 2024 May; 14(1):11993. PubMed ID: 38796576
[TBL] [Abstract][Full Text] [Related]
7. Mendelian randomization to assess causal effects of blood lipids on coronary heart disease: lessons from the past and applications to the future.
Burgess S; Harshfield E
Curr Opin Endocrinol Diabetes Obes; 2016 Apr; 23(2):124-30. PubMed ID: 26910273
[TBL] [Abstract][Full Text] [Related]
8. Mendelian randomization evaluation of causal effects of fibrinogen on incident coronary heart disease.
Ward-Caviness CK; de Vries PS; Wiggins KL; Huffman JE; Yanek LR; Bielak LF; Giulianini F; Guo X; Kleber ME; Kacprowski T; Groß S; Petersman A; Davey Smith G; Hartwig FP; Bowden J; Hemani G; Müller-Nuraysid M; Strauch K; Koenig W; Waldenberger M; Meitinger T; Pankratz N; Boerwinkle E; Tang W; Fu YP; Johnson AD; Song C; de Maat MPM; Uitterlinden AG; Franco OH; Brody JA; McKnight B; Chen YI; Psaty BM; Mathias RA; Becker DM; Peyser PA; Smith JA; Bielinski SJ; Ridker PM; Taylor KD; Yao J; Tracy R; Delgado G; Trompet S; Sattar N; Jukema JW; Becker LC; Kardia SLR; Rotter JI; März W; Dörr M; Chasman DI; Dehghan A; O'Donnell CJ; Smith NL; Peters A; Morrison AC
PLoS One; 2019; 14(5):e0216222. PubMed ID: 31075152
[TBL] [Abstract][Full Text] [Related]
9. Relation of depressive mood to plasminogen activator inhibitor, tissue plasminogen activator, and fibrinogen levels in patients with versus without coronary heart disease.
Lahlou-Laforet K; Alhenc-Gelas M; Pornin M; Bydlowski S; Seigneur E; Benetos A; Kierzin JM; Scarabin PY; Ducimetiere P; Aiach M; Guize L; Consoli SM
Am J Cardiol; 2006 May; 97(9):1287-91. PubMed ID: 16635597
[TBL] [Abstract][Full Text] [Related]
10. The association between plasminogen activator inhibitor type 1 (PAI-1) levels, PAI-1 4G/5G polymorphism, and myocardial infarction: a Mendelian randomization meta-analysis.
Nikolopoulos GK; Bagos PG; Tsangaris I; Tsiara CG; Kopterides P; Vaiopoulos A; Kapsimali V; Bonovas S; Tsantes AE
Clin Chem Lab Med; 2014 Jul; 52(7):937-50. PubMed ID: 24695040
[TBL] [Abstract][Full Text] [Related]
11. Causal Associations of Adiposity and Body Fat Distribution With Coronary Heart Disease, Stroke Subtypes, and Type 2 Diabetes Mellitus: A Mendelian Randomization Analysis.
Dale CE; Fatemifar G; Palmer TM; White J; Prieto-Merino D; Zabaneh D; Engmann JEL; Shah T; Wong A; Warren HR; McLachlan S; Trompet S; Moldovan M; Morris RW; Sofat R; Kumari M; Hyppönen E; Jefferis BJ; Gaunt TR; Ben-Shlomo Y; Zhou A; Gentry-Maharaj A; Ryan A; ; Mutsert R; Noordam R; Caulfield MJ; Jukema JW; Worrall BB; Munroe PB; Menon U; Power C; Kuh D; Lawlor DA; Humphries SE; Mook-Kanamori DO; Sattar N; Kivimaki M; Price JF; Davey Smith G; Dudbridge F; Hingorani AD; Holmes MV; Casas JP
Circulation; 2017 Jun; 135(24):2373-2388. PubMed ID: 28500271
[TBL] [Abstract][Full Text] [Related]
12. Diet-Derived Circulating Antioxidants and Risk of Coronary Heart Disease: A Mendelian Randomization Study.
Luo J; le Cessie S; van Heemst D; Noordam R
J Am Coll Cardiol; 2021 Jan; 77(1):45-54. PubMed ID: 33413940
[TBL] [Abstract][Full Text] [Related]
13. Sex-specific effect of serum urate levels on coronary heart disease and myocardial infarction prevention: A Mendelian randomization study.
Yang F; Lu Y; Chen S; Wang K; Hu T; Cui H
Nutr Metab Cardiovasc Dis; 2022 May; 32(5):1266-1274. PubMed ID: 35197211
[TBL] [Abstract][Full Text] [Related]
14. Genetic Association and Potential Mediators between Sarcopenia and Coronary Heart Disease: A Bidirectional Two-Sample, Two-Step Mendelian Randomization Study.
He J; Huang M; Li N; Zha L; Yuan J
Nutrients; 2023 Jul; 15(13):. PubMed ID: 37447340
[TBL] [Abstract][Full Text] [Related]
15. Evaluating the relationship between alcohol consumption, tobacco use, and cardiovascular disease: A multivariable Mendelian randomization study.
Rosoff DB; Davey Smith G; Mehta N; Clarke TK; Lohoff FW
PLoS Med; 2020 Dec; 17(12):e1003410. PubMed ID: 33275596
[TBL] [Abstract][Full Text] [Related]
16. Plasminogen activator inhibitor-1 gene: selection of tagging single nucleotide polymorphisms and association with coronary heart disease.
Su S; Chen S; Zhao J; Huang J; Wang X; Chen R; Gu D
Arterioscler Thromb Vasc Biol; 2006 Apr; 26(4):948-54. PubMed ID: 16424345
[TBL] [Abstract][Full Text] [Related]
17. HDL Cholesterol Metabolism and the Risk of CHD: New Insights from Human Genetics.
Vitali C; Khetarpal SA; Rader DJ
Curr Cardiol Rep; 2017 Nov; 19(12):132. PubMed ID: 29103089
[TBL] [Abstract][Full Text] [Related]
18. Adult height, coronary heart disease and stroke: a multi-locus Mendelian randomization meta-analysis.
Nüesch E; Dale C; Palmer TM; White J; Keating BJ; van Iperen EP; Goel A; Padmanabhan S; Asselbergs FW; ; Verschuren WM; Wijmenga C; Van der Schouw YT; Onland-Moret NC; Lange LA; Hovingh GK; Sivapalaratnam S; Morris RW; Whincup PH; Wannamethe GS; Gaunt TR; Ebrahim S; Steel L; Nair N; Reiner AP; Kooperberg C; Wilson JF; Bolton JL; McLachlan S; Price JF; Strachan MW; Robertson CM; Kleber ME; Delgado G; März W; Melander O; Dominiczak AF; Farrall M; Watkins H; Leusink M; Maitland-van der Zee AH; de Groot MC; Dudbridge F; Hingorani A; Ben-Shlomo Y; Lawlor DA; ; Amuzu A; Caufield M; Cavadino A; Cooper J; Davies TL; ; Drenos F; Engmann J; Finan C; Giambartolomei C; Hardy R; Humphries SE; Hypponen E; Kivimaki M; Kuh D; Kumari M; Ong K; Plagnol V; Power C; Richards M; Shah S; Shah T; Sofat R; Talmud PJ; Wareham N; Warren H; Whittaker JC; Wong A; Zabaneh D; Davey Smith G; Wells JC; Leon DA; Holmes MV; Casas JP
Int J Epidemiol; 2016 Dec; 45(6):1927-1937. PubMed ID: 25979724
[TBL] [Abstract][Full Text] [Related]
19. Plasminogen activator inhibitor-1 activity in type 2 diabetes: a different relationship with coronary heart disease and diabetic retinopathy.
Brazionis L; Rowley K; Jenkins A; Itsiopoulos C; O'Dea K
Arterioscler Thromb Vasc Biol; 2008 Apr; 28(4):786-91. PubMed ID: 18239151
[TBL] [Abstract][Full Text] [Related]
20. Causal association between placental growth factor and coronary heart disease: a Mendelian randomization study.
Zuo B; Zhu S; Zhong G; Bu H; Chen H
Aging (Albany NY); 2023 Oct; 15(19):10117-10132. PubMed ID: 37787982
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
